| RLTY | XLRE | RLTY / XLRE | |
| Gain YTD | 7.975 | 2.727 | 292% |
| Net Assets | 264M | 7.46B | 4% |
| Total Expense Ratio | 1.19 | 0.08 | 1,487% |
| Turnover | 43.00 | 5.00 | 860% |
| Yield | 2.87 | 3.40 | 85% |
| Fund Existence | 4 years | 10 years | - |
| RLTY | XLRE | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 2 days ago 87% | 2 days ago 86% |
| Momentum ODDS (%) | 2 days ago 83% | 2 days ago 83% |
| MACD ODDS (%) | 2 days ago 85% | 2 days ago 84% |
| TrendWeek ODDS (%) | 2 days ago 80% | 2 days ago 83% |
| TrendMonth ODDS (%) | 2 days ago 84% | 2 days ago 81% |
| Advances ODDS (%) | 9 days ago 87% | 20 days ago 87% |
| Declines ODDS (%) | 7 days ago 85% | 7 days ago 84% |
| BollingerBands ODDS (%) | 2 days ago 84% | N/A |
| Aroon ODDS (%) | 2 days ago 90% | N/A |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| USOI | 49.87 | 0.61 | +1.23% |
| UBS ETRACS Crude Oil Shares Cov Cll ETN | |||
| THNR | 25.22 | 0.23 | +0.94% |
| Amplify Weight Loss Drug & Treatment ETF | |||
| LCLG | 60.58 | N/A | N/A |
| Logan Capital Broad Innovative Gr ETF | |||
| LAPR | 25.16 | N/A | N/A |
| Innovator Premium Inc 15 Bffr ETF - Aprl | |||
| IPAC | 72.65 | -1.22 | -1.65% |
| iShares Core MSCI Pacific ETF | |||
A.I.dvisor tells us that RLTY and O have been poorly correlated (+15% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RLTY and O's prices will move in lockstep.
| Ticker / NAME | Correlation To RLTY | 1D Price Change % | ||
|---|---|---|---|---|
| RLTY | 100% | +0.20% | ||
| O - RLTY | 15% Poorly correlated | +0.60% | ||
| SPG - RLTY | 14% Poorly correlated | +0.52% | ||
| PLD - RLTY | 13% Poorly correlated | +0.23% | ||
| SUI - RLTY | 11% Poorly correlated | -0.28% | ||
| INVH - RLTY | 10% Poorly correlated | -1.78% | ||
More | ||||